Tissue-Engineered Three-Dimensional Platforms for Disease Modeling and Therapeutic Development

用于疾病建模和治疗开发的组织工程三维平台

阅读:1

Abstract

Three-dimensional (3D) tissue-engineered models are under investigation to recapitulate tissue architecture and functionality, thereby overcoming limitations of traditional two-dimensional cultures and preclinical animal models. This review highlights recent developments in 3D platforms designed to model diseases in vitro that affect numerous tissues and organs, including cardiovascular, gastrointestinal, bone marrow, neural, reproductive, and pulmonary systems. We discuss current technologies for engineered tissue models, highlighting the advantages, limitations, and important considerations for modeling tissues and diseases. Lastly, we discuss future advancements necessary to enhance the reliability of 3D models of tissue development and disease. Impact Statement In this review, we describe recent progress in the development and application of three-dimensional (3D) tissue-engineered models of disease. We discuss common approaches to create 3D models from somatic and stem and progenitor cells using spheroids, organoids, biomaterials, and microphysiological systems. In addition, we describe the application of such systems to model various disorders, discover mechanisms of progression, and identify new therapeutics to combat disease, which will be useful for subsequent research and clinical translation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。